Question 1

Does JPMorgan Chase own ABT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 15,095,898 shares of ABT (Abbott Laboratories), worth $1.4B.

Question 2

How many shares of ABT does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 15,095,898 shares of ABT (Abbott Laboratories).

Question 3

What is JPMorgan Chase's ABT position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's ABT position is worth $1.4B.

Question 4

Is JPMorgan Chase buying or selling ABT?

Accepted Answer

In Q2 2026, JPMorgan Chase reduced its ABT position by 11,671,201 shares (-43.6%).

Question 5

When did JPMorgan Chase first buy ABT?

Accepted Answer

JPMorgan Chase already held ABT in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	15.1M	-43.6%	$1.4B	0.1%	$89.55	0
2026-Q1	Increased	26.8M	+20.6%	$2.7B	0.2%	$100.69	45
2025-Q4	Decreased	22.2M	-24.5%	$2.8B	0.2%	$122.25	0
2025-Q3	Decreased	29.4M	-25.2%	$3.9B	0.2%	$130.11	0
2025-Q2	Decreased	39.3M	-1.6%	$5.3B	0.3%	$131.53	0
2025-Q1	Increased	39.9M	+13.5%	$5.3B	0.4%	$127.69	43
2024-Q4	Increased	35.2M	+21.7%	$4B	0.3%	$108.31	46
2024-Q3	First report	28.9M	-	$3.3B	0.3%	$108.66	0

ABT8 quarters

ABT
8 quarters